Back
Integra Lifesciences Holdings Vs. Perspective Therapeutics Industry Stock Comparison
Sell
37
IART
Integra Lifesciences Holdings
Last Price:
23.90
Seasonality Move:
8.49%
Sell
30
CATX
Perspective Therapeutics
Last Price:
9.27
Seasonality Move:
28.97%
Sell
37
Integra Lifesciences Holdings (IART)
is a Sell
Is Integra Lifesciences Holdings a Buy, Sell or Hold?
- The current Integra Lifesciences Holdings [IART] share price is $23.31. The Score for IART is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- IART is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IART Stock Price Chart
What is Integra Lifesciences Holdings's stock price today?
-
The Integra Lifesciences Holdings share price today is $23.31
The current trend is moderately bullish and IART is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $9.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
IART Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.62 | Buy |
| Relative Strength Index (14 RSI): | 58.09 | Buy |
| Chaikin Money Flow: | -1203802 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.32 - 23.8) | Buy |
| Bollinger Bands (100): | (17.78 - 27.4) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 28.07 | Sell |
| Chaikin Money Flow: | -952055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.27 - 12.77) | Sell |
| Bollinger Bands (100): | (11.25 - 14.33) | Sell |
IART Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.95 | Sell |
| 20-day SMA: | 21.56 | Buy |
| 50-day SMA: | 19.37 | Buy |
| 200-day SMA: | 28.08 | Sell |
| 8-day EMA: | 23.96 | Sell |
| 20-day EMA: | 22.22 | Buy |
| 50-day EMA: | 21.13 | Buy |
| 200-day EMA: | 27.14 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.45 | Sell |
| 20-day SMA: | 11.83 | Sell |
| 50-day SMA: | 12.88 | Sell |
| 200-day SMA: | 12.8 | Sell |
| 8-day EMA: | 11.13 | Sell |
| 20-day EMA: | 11.74 | Sell |
| 50-day EMA: | 12.46 | Sell |
| 200-day EMA: | 11.73 | Sell |
Integra Lifesciences Holdings Earnings Growth & IART Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and an increase next year of $0.06 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and a decrease next year of $0.22 per share.
Integra Lifesciences Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||